Displaying items by tag:
The School of Medicine is celebrating AAPI heritage, lineage, and legacy by telling the stories of several AAPI faculty around campus. To begin, Herbert Chen, M.D., FACS, Fay Fletcher Kerner Endowed Chair of the Department of Surgery, shares his story of family, adolescence, and medical training in an honest and candid oration.
UAB received over $325 million in research funding from the National Institutes of Health (NIH) in 2020.
The School of Medicine will celebrate Match Day 2021 virtually on Friday, March 19.
Erin Snyder, M.D. and Mamerhi Okor, M.D. are this year’s winners of the highly regarded Brewer-Heslin Award.
The School of Medicine communications staff sat down with Dr. Nakano to gain insights about his research, UAB and the science community.
The UAB Department of Surgery has joined the National Institutes of Health SIREN network. SIREN will coordinate and lead high-quality multisite clinical trials to improve outcomes for patients who experience neurologic, cardiac, respiratory, hematologic and trauma emergency events.
UAB Hospital continues to be highly ranked by U.S. News and World Report, and is noted as the No. 1 hospital in Alabama.
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
There will be more than 33,000 brain tumors diagnosed in Americans this year, according to the National Cancer Institute; but a UAB neurosurgeon says advances in treatment paint a brighter outlook than in years past.
Five faculty projects were recently funded through an AMC21 initiative giving NIH-funded investigators incentive to submit a second R01.